Canada - English
Canada - Français
New data clarifies the benefit of chemotherapy in early-stage, node-positive breast cancer patients with Recurrence Score® results of 0 to 25.
For a refined risk estimateof local recurrence
The Oncotype DX GPS assay is fully covered by Medicare for localized prostate cancer patients.
Nuclear-specific vs. nuclear-agnostic AR-V7 testing
Help Stage II colon cancer patients understand the power of genomics
Your Oncotype DX score can help you decide.
Oncotype DX has helped thousands of women find out.
When Dan's Colon Recurrence Score came back low, he decided against chemotherapy.
Phone: +46 708 61 30 31
Email: European Customer Support
Partner: South Genetics Dominicana SRL
Calle Federico Geraldino, No. 47
Esq. Gustavo Mejia Ricart
Plaza Jenika, Suite 404
Santo Domingo, Rep. Dominicana
Phone: +1 809 5639733
Contact email: firstname.lastname@example.org
Contact: Judith Ortiz
Contact email: email@example.com
Partner: Grupo Amarey
Phone: +57 1 7447300 ext 2405
Contact email: firstname.lastname@example.org
Company website: www.grupoamarey.com
Partner:SouthGenetics México S.A de C.V.
Phone: +52 55 5202 9687
Contact email: oncotypeDX@southgenetics.com
Company website: www.southgenetics.com
Partner: GeneKor Medical
Phone: +30 210 603 2138
Fax: +30 210 603 2148
Contact email: email@example.com
Company website: www.genekor.com
Partner: BADAN (Banco de Drogas Antineoplásicas)
Phone: +58 2124000529 / +58 2124000555
Contact email: firstname.lastname@example.org / email@example.com
Company website: www.fundacionbadan.org
United States, Canada +1 866-662-6897 Email Customer Service Europe, Middle East, Africa +41 22 715 29 00 Email European Support Asia Pacific, Latin America +1 866-662-6897 Email International Customer Support
Order tests securely, access results quickly, sign documents, assign delegates, receive updates and more benefits available in one place.
Have questions? We're here to help.